Drug target · GRIN2A
GluN2A
Glutamate ionotropic receptor NMDA type subunit 2A
1 compound in the CNS pipeline acts on GluN2A.
Compounds targeting GluN2A
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Zelquistinel (GATE-251)Small molecule | PAM | — | Phase 2Major depressive disorder | Syndeio Biosciences, Inc. |